Zynex, Inc. (NASDAQ: ZYXI) has voluntarily entered into a Chapter 11 court-supervised financial restructuring with new financing from lenders.
The restructuring aims to create a new future for Zynex and demonstrates confidence in the positive changes made by the company.
Operations will continue as usual with no impact on patients, customers, or employees.
New Financial Restructuring
Zynex has embarked on a restructuring journey with the support of lenders to secure its long-term success.
Operational Continuity
The company assures normal operations will be maintained without disruptions to patients, customers, or staff.
Renewed Commitment
Emphasis on integrity in business practices and the pursuit of improving patients' quality of life remains a priority.
- Zynex's financial restructuring signals a strategic move to address financial challenges and pave the way for sustained growth.
- The positive outlook from lenders reflects confidence in the company's revamped business approach and commitment to excellence.
Zynex's proactive approach to financial restructuring sets the stage for a resilient future, ensuring continuity in operations and fostering confidence among stakeholders.